The within-host evolutionary dynamics of TB remain unclear, and underlying biological 13 characteristics render standard population genetic approaches based upon the Wright-Fisher 14 model largely inappropriate. In addition, the compact genome combined with an absence of 15 recombination is expected to result in strong purifying selection effects. Thus, it is imperative to 16 establish a biologically-relevant evolutionary framework incorporating these factors in order to 17 enable an accurate study of this important human pathogen. Further, such a model is critical for 18 inferring fundamental evolutionary parameters related to patient treatment, including mutation 19 rates and the severity of infection bottlenecks. We here implement such a model and infer the 20 underlying evolutionary parameters governing within-patient evolutionary dynamics. Results 21 demonstrate that the progeny skew associated with the clonal nature of TB severely reduces 22 polymorphic sites per patient genome-wide. In addition, the observed site frequency spectrum 56 (SFS) is generally characterized by an abundance of rare variants (i.e., it is strongly left-skewed). 57
genetic diversity and that the neglect of this parameter in previous studies has led to significant 23 mis-inference of mutation rates. As such, our results suggest an underlying de novo mutation rate 24 that is considerably faster than previously inferred, and a progeny distribution differing 25 significantly from Wright-Fisher assumptions. This inference largely reconciles the seemingly 26 contradictory observations of both rapid drug-resistance evolution but extremely low levels of 27 genetic variation in both resistant and non-resistant populations. 28 29 30 31 INTRODUCTION 33 Tuberculosis (TB) is a public health threat worldwide (WHO, 2018) . Despite clear 34 motivation for study, the observed within-and between-host evolutionary dynamics of 35
Mycobacterium tuberculosis (M.TB) are not well understood, and results to date represent 36 something of a paradox. On the one hand, drug resistance evolves rapidly (Fonseca et al. 2015; 37 Eldholm et al. 2015) ; on the other, the genomic characteristics of M.TB do not appear conducive 38 for such rapid adaptation, with inferred mutation rates being amongst the slowest of any human 39 pathogen (Rocha et al. 2006; Ford et al. 2011; Ford et al. 2013; Colangeli et al. 2014; Payne et 40 al. 2019; Menardo et al. 2019 ) and remarkably little genetic variation observed within or 41 between hosts. Furthermore, purifying selection has been argued to play both a dominant as well 42 as a weak role in shaping patterns of variation (Hershberg et al. 2008; Pepperell et al. 2013) , and 43 demographic estimates suggest a population history of TB that either matches or is uncorrelated 44 with that of its human host (Comas et al. 2013; Bos et al. 2014; Brites et al. 2015; Eldholm et al. 45 2016) . 46 47 To obtain a more robust understanding of TB evolutionary dynamics, it is essential to 48 first appreciate that between-population observations are simply an aggregation of within-49 population processes. As such, studying the population genetics of within-patient data is critical 50 to understanding the genetic differences observed between patients as well as their treatment 51 outcomes. Fortunately, recent advances in sequencing technologies have allowed for more 52 abundant and higher quality within-patient data. These published datasets have revealed a few 53 common features of M.TB, including low-levels of genome-wide variation. For instance, Trauner 54 et al. (2017) deep-sequenced twelve patients across four-time points and observed fewer than 50 55 in earlier estimates as these mutations are unlikely to be sampled as segregating variation or as 156 fixed differences. However, as these mutations are important for shaping diversity via both 157 purifying selection and background selection effects, and as our interest is in understanding the 158 total rate at which all de novo mutations are input into the population, we considered the total 159 rather than the neutral mutation rate. In order to infer this parameter within the context of an 160 appropriate progeny-skew model, μ was drawn from a prior uniform distribution between 1e-9 161 and 9e-6 per site per generation. 162
163
Following an initial burn-in period of 10N generations, we considered a three-stage 164 demographic model characterizing a single patient infection: moving forward in time, we 165 describe 1) a neutral equilibrium population of size N, 2) an initial infection bottleneck leading to 166 an instantaneous population reduction to size N2, and 3) a subsequent population size recovery to 167 size N. In stage 1, we modeled a population of size N = 1,000. In order to quantify the effects of 168 underlying assumptions pertaining to population size, additional simulations and inference were 169 performed at N = 25,000. During stage 2, the severity of the population bottleneck (β) was 170 sampled from ~U[0.001, 0.1], where N2 = N*β -as the distribution of infection size in humans 171 is unknown. However, it has been reported that in cattle TB (M. bovis) infection can be 172 established by a single cell forming unit (Dean et al. 2005) . During stage 2, the degree of 173 progeny skew (or Ψ) was sampled from a prior distribution of ~U[0, 0.2]. A value of 0 174 corresponds to the standard WF model. Progeny skew was simulated following the procedure of 175 Sackman et al. 2019 . In brief, one individual is chosen from the primary population A and 176 founds a separate subpopulation B, the single generation unidirectional migration rate from B to 177 A is set to Ψ, and the chosen individual thus contributes NΨ offspring to the following generation 178 of A. A series of mate choice callbacks in SLiM force the migration rate to be exact rather than 179 stochastic (see Supplementary Materials of Sackman et al. 2019) . Subpopulation B is removed, 180 the next generation begins, and a new individual is randomly sampled for the following 181 generation. As such, each generation is a combination of N(1-Ψ) replacement events and a single 182 sweepstakes event of magnitude NΨ. To emulate patient sampling at the onset of symptoms 183 (approximately three months minimum (Behr et al. 2018 )), we allowed stage 2 to run for 90 184 generations, assuming a generation time of 24 hours (Cole et al. 1998) , and stage 3 to run for 910 185 generations before outputting genome alignments in ms format. Thus, the total generation time 186 of our model was 11N. 187 188 Drawing from these prior distributions, 10,000 points (i.e., parameter combinations) were 189 sampled. For each parameter combination, we conducted 1,000 replicates in order to characterize 190 both the mean and variance. Summary statistics were calculated in the R package PopGenome 191 version 2.6.1 (Pfeifer et al. 2014). 192 193 
Data analysis and joint posterior estimates 194
For comparison to patient data, we examined the distribution and mean of segregating 195 sites in samples published by Trauner et al. (2017). 196 (https://zenodo.org/record/322377#.XO2CAy2ZNBw). A subset of 1,000 populations was 197 simulated under the conditions described above. Given that patient data are subject to stringent 198 filtering criteria, removing SNPs under a particular frequency cut-off, it was necessary to filter 199 the simulated data to allow fair comparison. Thus, 100 genomes were sampled per each 200 simulated population, and variants < 2% frequency were filtered out before the calculation of 201 summary statistics (Table S1 ). Afterward, only genomes with ³ 2 segregating sites were 202 considered for further analyses, and the fraction of "invariable genomes" was noted for 203 comparison to patient samples ( Figure 2 and Table S1 ). 204
205

RESULTS & DISCUSSION
206
Considering levels of variation 207
We here report the first joint consideration of mutation rate, purifying selection, infection 208 history, and progeny-skew in M.TB populations. A correlation of summary statistics (Figure 1 ) 209 demonstrates that while mutation rate (μ) increases the number of segregating sites as expected, 210 progeny skew (Ψ) acts to reduce variation. Furthermore, as the Ψ-parameter is of relevance every 211 generation (i.e., every reproduction event), the impact of this previously unconsidered progeny 212 skew on levels of variation is in fact much stronger than the single bottleneck event associated 213 with infection. Considering the full distribution of sampled μ values ( Figure S1 ), it is apparent 214 that Ψ drastically reduces the average proportion of segregating sites genome-wide even for fast 215 mutation rates, and that the probability of producing genomes devoid of any variation will 216 naturally increase as μ decreases. while μ would not be expected to strongly correlate with the shape of the SFS (here summarized 229 by Tajima's D) for neutral mutations, it does so here given that we explicitly account for the 230 input of deleterious mutations (see Methods). 231
232
In order to consider a range of μ consistent with observed data -once pervasive purifying 233 selection and progeny skew have been taken in to account -two examples of patient data 234 collected by Trauner et al. (2017) representing low (20 segregating sites genome-wide) and high 235 (50 segregating sites genome-wide) variation samples were plotted and compared to the 236 simulated data. In order to compare simulated data with patient data, the same filtering steps 237 must be applied. In this case, SNPs under 2% frequency were filtered in the empirical data, and 238 thus, the simulated data were similarly filtered in order to be comparable (Figure 2) . 239 240 Figure 2. Log scale distribution of segregating sites above 2% frequency, as a function of 241 mutation rate (μ) and progeny skew (Ψ). For each parameter combination (1,000 in total) of μ 242 and Ψ drawn from the prior distributions, 1,000 replicates were simulated, with the mean given 243 by the black dot and the standard deviation given by the gray bars. Each panel corresponds to a 244 different order of magnitude of mutation rate range: (Α) 1e-6 to 9e-6, (B) 1e-7 to 9e-7, (C) 1e-8 245 to 9e-8, and (D) 1e-9 to 9e-9. The colored lines correspond to two examples of the proportion of 246 segregating sites observed genome-wide in empirical patient data: 20 segregating sites as a mean 247 (orange), and 50 segregating sites from patient_10 (blue) (Trauner et al. 2017) . As shown, the 248 range of segregating sites for the fast mutation rates (panels A and B), result in expectations 249 much larger than that observed in patient data, regardless of Ψ. Conversely, the slowest mutation 250 rate (panel D), result in too little variation, except under WF conditions (i.e., Ψ near 0) which are 251 known to be violated given clonality. Thus, rates on the order of 1e-8 to 9e-8 (panel C) appear to 252 well explain the range of variation observed in patient data, and further imply values of Ψ 253 ranging roughly from 0.05 to 0.1, consistent with values previously estimated for within-host 254 virus data (Sackman et al. 2019) . 255
256
As shown, fast mutation rates (μ on the order of 1e-6 and 1e-7) routinely produce 257 expected numbers of segregating sites far above that observed in patients, regardless of other 258 parameter values, while slow mutation rates (μ on the order of 1e-9) generally result in too little 259 variation to match observation. This result is of interest as M.TB mutation rates are generally 260 believed to be exceedingly slow (Sherman et al. 2011 ) -though importantly, this inference has 261 largely neglected the important contribution of these additional evolutionary processes. Thus, 262 once accounting for the diversity-reducing effects inherent to clonality, as well as the extent of 263 purifying selection effects inherent to a compact, non-recombining genome, it is evident that the 264 de novo mutation rate is likely faster than previously believed, with mutation rates on the order 265 1e-8 well matching the range of observed data ( Figure 2 ). In addition, in order to consider the 266 impact of underlying assumptions pertaining to population size, simulations were re-performed 267 with a 25x larger population size. As shown in Figure S2 , owing to these diversity reducing 268 effects, mutations rates on the order of 1e-8 remain the best fit to observed levels of variation, 269 with slower mutation rates still producing too little variation and too many invariable genomes to 270 be consistent with patient data. 271
272
Considering distributions of variation 273
For the general range of μ identified above, the number of genome-wide segregating sites 274 in simulated population data ranged from a minimum average of 2.1 to a maximum average of 275 78.7 SNPs (Table S1 ), depending on the combination of μ and Ψ drawn from the priors. 276
Specifically, higher values of μ may be off-set by higher values of Ψ, resulting in a similar 277 number of segregating sites for multiple parameter combinations. For example, for the patient 278 sample containing 10 SNPs, simulation results demonstrate that μ = 8.13e-08 and a Ψ =0.06 279 would produce an average of 10.15 +/-4.64 SNPs, potentially suggesting a good fit to the data. 280 However, μ = 3.1e-08 and a Ψ =0.02 can also generate similar results, yielding 10.40 +/-4.45 281
SNPs. More generally, this ridge in the posterior distributions ( Figure 3A ) between these two 282 parameters suggests that they will be difficult to estimate independently if only levels of 283 variation are used. Posterior density for the severity of the infection bottleneck (N2). The X-axis gives the number 291 of genomes at the time of infection reduced from 1,000. While the posterior distribution is non-292 uniform, the observation that all tested values remain consistent with patient data strongly 293 suggests that there is not sufficient information in the data to estimate this third parameter (i.e., 294 size of the bottleneck, in addition to μ and Ψ). 295 296 Thus, while comparisons with general levels of variation are useful for identifying a 297 range as in the above section, more information is needed to parse values further. Importantly, 298 previous theoretical results (Eldon & Wakeley 2016; Matuszewski et al. 2018 ) have well 299 described the effect of Ψ on the observed distribution of genetic variation (i.e., SFS). To utilize 300 this information, a general summary of the SFS, Tajima's D (1989) , was calculated on the 301 filtered simulated data. As shown ( Figure S3 ), the shape of the SFS, and thus the value of the D-302 statistic, is related to the value of Ψ. As the degree of progeny skew initially increases, D 303 becomes increasingly negative, as previously described. However, as progeny distributions 304 become highly skewed, levels of variation are sharply reduced, resulting in an apparent increase 305
in D values ( Figure S3 ). Increasing D values could also be a result of the underlying filtering 306 criteria, as after filtering simulations to match real data with segregating sites > 2%, D values 307 increased proportionally ( Figure S4 ). However, Tajima's D is consistently negative in all 308 mutation ranges, even after filtering. 309 310 Parameter inference from patient samples 311 Thus, we next considered these results in light of published patient data. Recent 312 publications have suggested that NGS technologies could facilitate personalized treatment in TB 313 patients, allowing for improved outcomes (Copin et al. 2016; Cancino-Muñoz et al. 2019) . To 314 utilize such data, however, it is vital to understand the evolutionary dynamics shaping within-315 host M.TB diversity. As an illustrative example, we have re-examined the number of segregating 316 sites in patient samples and estimated a mean ~10 segregating sites per sample (Trauner et al. 317 2017) ( Figure S5 ). Further, using the results and expectations obtained above regarding the level 318 and distribution of variation, the patient data appear best fit by simulated populations with μ 319 values ranging from 7.3e-9 to 3.8e-7, with the strongest posterior density at μ ~ 6e-8 and Ψ ~ 320 0.06 ( Figure 3A) . Notably, faster μ values could produce similar results, but only if Ψ 321 proportions are in excess of 0.15 ( Figure 3A) . 322
323
In addition, owing to the strong per-generation reductions associated with progeny skew, 324 there remains no signal in the data to estimate the severity of the infection bottleneck accurately 325 ( Figure 3B ). Specifically, while there is an increase in density towards stronger bottleneck 326 values, the posterior distribution is not notably distinct from the prior distribution ~U[0.001, 0.1] 327 ( Figure 3B ). Apart from the population size reduction associated with infection, these results 328 have important implications for the ability to detect other parameters of clinical interest -329 namely, the presence of selective sweeps associated with beneficial mutations (e.g., potentially 330 owing to drug-resistance). First, while there is strong statistical power to infer both μ and Ψ from 331 patient data, there is little power to detect isolated events in the past ( Figure 3B ). This result, 332 though unexpected under standard WF assumptions, is intuitive given the non-WF progeny 333 distributions related to clonality. Namely, the diversity reduction associated with a single 334 bottleneck event multiple generations in the past is not discernible from the per-generation 335 diversity reduction related to clonal reproduction. Further, given that a selective sweep is, in fact, 336 a type of population bottleneck (Barton 1998), this result also demonstrates that detecting 337 selective sweeps associated with resistance mutations in this non-recombining organism, based 338 on levels and patterns of genomic variation, will be exceedingly difficult. However, this 339 observation well reconciles the fact that levels of variation do not appear significantly different 340 between resistant and non-resistant M.TB patient populations (Trauner et al. 2017 ) -that is, these 341 additional evolutionary processes are shaping variation so strongly, that the presence or absence 342 of a resistance-associated selective sweep does not result in strongly differentiable expectations. 343 344
Implications for characterizing the history of TB in humans 345
A topic of wide-spread interest in the literature pertains to the history of TB in the human 346 host. This inference has primarily been made within a phylogenetic context, relying on the 347 construction of a single consensus sequence per patient. While such a comparison of consensus 348 sequences can be highly mis-leading when making evolutionary inference (see Renzette et al. 349 2017) , these age-estimates also inherently rely on an accurate knowledge of mutation rates in 350 order to invoke the 'clock-like' accumulation of neutral mutations as a proxy for time (Menardo 351 et al. 2019) . As our results demonstrate that previous mutation rate estimates have likely been 352 downwardly-biased, it is of interest to consider what these revised mutation rates would imply 353 for this evolutionary history. However, there are at least three difficulties in directly comparing 354 population-level estimates with previous consensus-based phylogenetic inference. Firstly, 355 estimates are generally given per year, whereas the preferred evolutionary rate is per generation 356 (as given here). There is support for one generation per day as a conversion (Cole et al. 1998), 357 though further study is necessary to quantify the correct scaling factor. Secondly, when invoking 358 a divergence-based clock, previous studies are measuring the neutral mutation rate, given that the 359 rate of mutation is equivalent to the rate of divergence for neutral mutations only (Kimura 1968). 360
However, we are here interested in the total mutation rate (that is, the rate at which neutral and 361 non-neutral mutations arise per generation); therefore, our rate must be parsed into neutral and 362 non-neutral components to enable appropriate comparison. Similar to the first point, additional 363 research is necessary in order to better quantify the distribution of fitness effects in M.TB, as 364 understanding the fraction of total mutations represented by neutral mutations is necessary for 365 the conversion. Finally, we here consider the alleles segregating within a population for 366 inference (i.e., within a patient), whereas previous studies often call a consensus sequence per 367 patient (i.e., per population) and make inferences based on a collection of such consensus 368 sequences. Such a summary of population-level variation into a single sequence is difficult to 369
interpret, though what is evident is that a great majority of rare alleles will be neglected, and thus 370 only a small subset of total variation (i.e., common alleles) will be considered (Renzette et al. 371 2017) . As such, we propose that future evolutionary inference pertaining to TB would benefit 372 tremendously from a full consideration of within-patient diversity, as we demonstrate here. In 373 sum, any direct comparison with consensus-based phylogenetic age estimates would be overly 374 speculative at this juncture. 375 376 CONCLUSIONS 377 TB patient infection dynamics have remained enigmatic. We here argue that much of the 378 difficulty in interpreting patterns of variation and evolution has owed to an inappropriate 379 underlying null model, relying on classical expectations developed for organisms with very 380 different underlying biological properties. Fortunately, recent theoretical extensions in non-WF 381 and alternative coalescent models, more appropriate for clonally reproducing organisms, have 382 created an opportunity to revisit existing M.TB patient data. By accounting for the pervasive 383 purifying selection effects associated with this non-recombining, highly-coding genome, as well 384 as the skewed progeny distributions inherent to clonal reproduction, we have provided improved 385 insights into the evolutionary dynamics shaping within-host variation. Further, through a 386 consideration of these diversity-reducing effects, results suggest an underlying de novo mutation 387 rate that is considerably faster than previously inferred. This largely reconciles the seemingly 388 contradictory observations of both rapid resistance evolution, but extremely low levels of 389 population variation. Namely, the population mutation rate may indeed be sufficiently fast to 390 provide a steady input of beneficial mutations, explaining the rapid resistance evolution 391 clinically observed. However, recurrent purifying selection and progeny skew act together to 392 rapidly eliminate segregating variation from the population, reconciling the minimal levels of 393 variation observed as well as the general homogeneity in levels and distributions of variation in 394 both resistant and non-resistant patient samples alike. Furthermore, the role of these per-395 generation evolutionary forces in shaping patterns of variation is sufficiently strong that periodic 396 events, including the infection-associated bottleneck and selective sweeps centered on drug-397 resistance mutations, will be challenging to detect and quantify on top of these more common 398 and Ψ drawn from the prior (10,000 in total), 1,000 replicates were simulated, with the mean 586 given by the black dot and the standard deviation given by the gray bars. Ψ proportions are given 587 on the X-axis, while the proportion of segregating sites observed in the genome are given on the 588 Y-axis. Each panel corresponds to a different order of magnitude of mutation rate: (Α) 1e-6 to 589 9e-6, (B) 1e-7 to 9e-7, (C) 1e-8 to 9e-8, and (D) 1e-9 to 9e-9. The colored lines correspond to each parameter combination of μ and Ψ drawn from the prior distributions (10,000 in total), 610 1,000 replicates were simulated, with the mean given by the black dot and the standard deviation 611
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